Global Portfolio Bausch + Lomb Canada operates within a broad global eye health portfolio including over-the-counter products, dietary supplements, ophthalmic pharmaceuticals, contact lenses and surgical devices, presenting multiple cross-sell opportunities across professional and consumer channels.

CE Mark Momentum Recent CE Mark approvals for enVista Aspire intraocular lenses open doors for EU-based clinicians and distributors, suggesting a pathway to expand surgical lens offerings and related service agreements in new markets.

Strategic Acquisitions Acquisition of Trukera Medical strengthens the surgical presence in the US and enhances the dry eye franchise, indicating potential for bundled product or service collaborations, training programs, and enhanced distribution with US-based partners.

Regulatory & Campaigns Joint initiatives such as Faces of Glaucoma and regulatory campaigns signal opportunities to co-market awareness programs, educational events, and patient engagement packages that can drive adoption of newer diagnostics and therapies.

Growth in Healthcare Platforms Active participation in industry events (SFO Congress) and published product launches reflect a growth-oriented strategy; leverage these platforms to schedule key account outreach, pilot programs, and early-access deals with eye care providers.